At the conclusion of this activity, the participant should be able to:

• Describe the mechanisms leading to increased portal pressure and etiologies of portal hypertension.
• Recognize the shift away from requiring histological or radiological diagnosis of cirrhosis to using noninvasive testing to instead identify compensated advanced chronic liver disease and clinically significant portal hypertension.
• Understand the role of disease management, use of medications such as non selective beta-blockers to prevent complications and recognize the impact of decompensation on overall prognosis.